Results 11 to 20 of about 84,576 (334)

Chronic thromboembolic pulmonary hypertension [PDF]

The Lancet Respiratory Medicine, 2014
Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare but debilitating and life-threatening complication of acute pulmonary embolism. CTEPH results from persistent obstruction of pulmonary arteries and progressive vascular remodelling. Not all patients presenting with CTEPH have a history of clinically overt pulmonary embolism. The diagnostic
Marius M, Hoeper, Michael M, Madani, Norifumi, Nakanishi, Bernhard, Meyer, Serghei, Cebotari, Lewis J, Rubin   +5 more
core   +11 more sources

Chronic Thromboembolic Pulmonary Hypertension [PDF]

Current Treatment Options in Cardiovascular Medicine, 2000
Chronic thromboembolic pulmonary hypertension is substantially more prevalent than is generally recognized. Most patients affected with this disorder are severely symptomatic, but in the early stages, the diagnosis may be hard to make. Despite an estimated incidence of 2500 to 25,000 cases annually in the United States alone, these patients continue to
Ho Joong Kim
openalex   +5 more sources

Chronic thromboembolic pulmonary hypertension [PDF]

La Presse Médicale, 2015
Chronic thromboembolic pulmonary hypertension (CTEPH) is a form of pulmonary hypertension (PH) characterized by the persistence of thromboembolic obstructing the pulmonary arteries as an organized tissue and the presence of a variable small vessel arteriopathy.
Caroline, O'Connell, David, Montani, Laurent, Savale, Olivier, Sitbon, Florence, Parent, Andrei, Seferian, Sophie, Bulifon, Elie, Fadel, Olaf, Mercier, Sacha, Mussot, Dominique, Fabre, Philippe, Dartevelle, Marc, Humbert, Gérald, Simonneau, Xavier, Jaïs   +14 more
core   +6 more sources

Chronic thromboembolic pulmonary hypertension [PDF]

European Respiratory Journal, 2004
Pulmonary arterial hypertension is a severe disease that has been ignored for a long time. However, over the past 20 yrs chest physicians, cardiologists and thoracic surgeons have shown increasing interest in this disease because of the development of new therapies, that have improved both the outcome and quality of life of patients, including ...
P, Dartevelle, E, Fadel, S, Mussot, A, Chapelier, P, Hervé, M, de Perrot, J, Cerrina, F L, Ladurie, D, Lehouerou, M, Humbert, O, Sitbon, G, Simonneau   +11 more
openaire   +4 more sources

Chronic Thromboembolic Pulmonary Hypertension [PDF]

Current Treatment Options in Cardiovascular Medicine, 2010
The pulmonary hypertension (PH) and right heart dysfunction that results from chronic thromboembolic involvement of the pulmonary vascular bed is potentially curable with surgical endarterectomy. Over the past several decades, growing clinical experience has brought about increased recognition of this treatable form of PH.
Wittine, Lara M., Auger, William R.
openaire   +6 more sources

Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension: a clinical consensus statement of the ESC working group on pulmonary circulation and right ventricular function

European Heart Journal, 2023
The current treatment algorithm for chronic thromboembolic pulmonary hypertension (CTEPH) as depicted in the 2022 European Society of Cardiology (ESC)/European Respiratory Society (ERS) guidelines on the diagnosis and treatment of pulmonary hypertension (
I. Lang, A. Andreassen, A. Andersen, H. Bouvaist, G. Coghlan, P. Escribano-Subías, P. Jansa, G. Kopeć, M. Kurzyna, H. Matsubara, B. Meyer, M. Palazzini, M. Post, P. Pruszczyk, L. Räber, M. Roik, S. Rosenkranz, C. Wiedenroth, Carlo Redlin-Werle, P. Brenot   +19 more
semanticscholar   +1 more source

Differences in health policies for drug availability in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension across Latin America

Pulmonary Circulation, 2022
Treatment for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension in Latin America differs between countries, with regard to disease etiology, health insurance coverage, and drug availability.
Mauricio Orozco‐Levi, Jorge Cáneva, Caio Fernandes, Ricardo Restrepo‐Jaramillo, Nayeli Zayas, Rafael Conde, Mirta Diez, Carlos Jardim, Manuel C. Pacheco Gallego, Luciano Melatini, Héctor Valdéz, Tomás Pulido   +11 more
doaj   +1 more source

Percutaneous Interventional Therapy for Chronic Thromboembolic Pulmonary Hypertension

Structural Heart, 2023
Chronic thromboembolic pulmonary hypertension is a form of precapillary pulmonary hypertension resulting from the incomplete resolution of pulmonary thromboemboli and formation of chronic, fibrotic, flow-limiting obstructions within the pulmonary ...
Ehtisham Mahmud, MD, Lawrence Ang, MD
doaj   +1 more source

Multidisciplinary Approach to Chronic Thromboembolic Pulmonary Hypertension: Role of Radiologists.

Radiographics, 2023
Management of chronic thromboembolic pulmonary hypertension (CTEPH) should be determined by a multidisciplinary team, ideally at a specialized CTEPH referral center.
L. Hahn, D. Papamatheakis, T. Fernandes, D. Poch, Jenny Z. Yang, Jody Shen, C. Hoh, A. Hsiao, K. Kerr, V. Pretorius, M. Madani, Nick H. Kim, S. Kligerman   +12 more
semanticscholar   +1 more source

Pathophysiology and Treatment of Chronic Thromboembolic Pulmonary Hypertension

International Journal of Molecular Sciences, 2023
Chronic thromboembolic pulmonary hypertension (CTEPH) is a condition in which an organic thrombus remains in the pulmonary artery (PA) even after receiving anticoagulation therapy for more than 3 months and is complicated by pulmonary hypertension (PH ...
N. Otani, R. Watanabe, Takashi Tomoe, Shigeru Toyoda, T. Yasu, T. Nakamoto   +5 more
semanticscholar   +1 more source